| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 27 | 2024 | 3533 | 3.090 |
Why?
|
| Heart Defects, Congenital | 32 | 2024 | 4586 | 2.880 |
Why?
|
| Hypoplastic Left Heart Syndrome | 11 | 2023 | 574 | 2.080 |
Why?
|
| Tetralogy of Fallot | 7 | 2024 | 623 | 1.590 |
Why?
|
| Pulmonary Artery | 14 | 2023 | 1912 | 1.590 |
Why?
|
| Ventricular Outflow Obstruction | 6 | 2018 | 272 | 1.560 |
Why?
|
| Truncus Arteriosus, Persistent | 3 | 2020 | 63 | 1.400 |
Why?
|
| Fiber Optic Technology | 4 | 2021 | 289 | 1.210 |
Why?
|
| Norwood Procedures | 7 | 2023 | 182 | 1.130 |
Why?
|
| Heart Septal Defects | 4 | 2024 | 192 | 1.100 |
Why?
|
| Heart Septal Defects, Ventricular | 3 | 2022 | 488 | 1.090 |
Why?
|
| Heart Valve Diseases | 3 | 2020 | 1072 | 1.000 |
Why?
|
| Aortic Valve | 4 | 2016 | 1921 | 0.980 |
Why?
|
| Fontan Procedure | 6 | 2019 | 779 | 0.960 |
Why?
|
| Heart Conduction System | 2 | 2020 | 1047 | 0.940 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2020 | 478 | 0.900 |
Why?
|
| Pulmonary Valve | 6 | 2024 | 437 | 0.860 |
Why?
|
| Pneumonectomy | 7 | 2005 | 1094 | 0.790 |
Why?
|
| Heart Transplantation | 13 | 2015 | 3123 | 0.730 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2019 | 30 | 0.700 |
Why?
|
| Atrioventricular Block | 1 | 2020 | 120 | 0.660 |
Why?
|
| Williams Syndrome | 1 | 2020 | 187 | 0.640 |
Why?
|
| Microscopy, Confocal | 3 | 2020 | 1971 | 0.630 |
Why?
|
| Polytetrafluoroethylene | 2 | 2018 | 233 | 0.620 |
Why?
|
| Pacemaker, Artificial | 1 | 2023 | 818 | 0.620 |
Why?
|
| Mitochondria, Muscle | 1 | 2016 | 171 | 0.530 |
Why?
|
| Intraoperative Care | 1 | 2019 | 767 | 0.510 |
Why?
|
| Heart Ventricles | 6 | 2023 | 3820 | 0.500 |
Why?
|
| Lung Transplantation | 12 | 2003 | 1155 | 0.480 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 834 | 0.480 |
Why?
|
| Lung | 14 | 2015 | 9852 | 0.470 |
Why?
|
| Bioprosthesis | 3 | 2016 | 596 | 0.460 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2016 | 476 | 0.460 |
Why?
|
| Pulmonary Circulation | 4 | 2023 | 739 | 0.440 |
Why?
|
| Tricuspid Valve | 2 | 2022 | 403 | 0.440 |
Why?
|
| Heart Rate | 2 | 2020 | 4092 | 0.410 |
Why?
|
| Infant | 30 | 2024 | 35129 | 0.400 |
Why?
|
| Vena Cava, Inferior | 1 | 2014 | 436 | 0.390 |
Why?
|
| Tracheobronchomalacia | 3 | 2023 | 131 | 0.390 |
Why?
|
| Heart Valve Prosthesis | 3 | 2016 | 1488 | 0.380 |
Why?
|
| Peptic Ulcer | 2 | 2024 | 223 | 0.380 |
Why?
|
| Heart Arrest | 3 | 2019 | 1470 | 0.370 |
Why?
|
| Infant, Newborn | 27 | 2023 | 25618 | 0.370 |
Why?
|
| Child | 35 | 2023 | 77679 | 0.360 |
Why?
|
| Child, Preschool | 24 | 2021 | 40992 | 0.350 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2016 | 1534 | 0.350 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2014 | 933 | 0.350 |
Why?
|
| Reperfusion Injury | 12 | 2003 | 1026 | 0.330 |
Why?
|
| Myocardium | 3 | 2016 | 4776 | 0.320 |
Why?
|
| Length of Stay | 4 | 2019 | 6308 | 0.310 |
Why?
|
| Heart | 3 | 2023 | 4465 | 0.310 |
Why?
|
| Blood Vessel Prosthesis Implantation | 4 | 2018 | 1390 | 0.300 |
Why?
|
| Sinoatrial Node | 2 | 2020 | 101 | 0.290 |
Why?
|
| Cyclohexanecarboxylic Acids | 6 | 2002 | 143 | 0.290 |
Why?
|
| Humans | 97 | 2024 | 744220 | 0.290 |
Why?
|
| Atrioventricular Node | 2 | 2020 | 182 | 0.280 |
Why?
|
| Airway Management | 2 | 2020 | 324 | 0.270 |
Why?
|
| Diagnostic Techniques, Respiratory System | 1 | 2005 | 12 | 0.270 |
Why?
|
| Reoperation | 7 | 2024 | 4203 | 0.260 |
Why?
|
| Retrospective Studies | 37 | 2024 | 77426 | 0.250 |
Why?
|
| Purines | 6 | 2002 | 594 | 0.240 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2010 | 314 | 0.240 |
Why?
|
| Mitral Valve Insufficiency | 5 | 2011 | 1421 | 0.240 |
Why?
|
| Sheep | 3 | 2023 | 1437 | 0.240 |
Why?
|
| Echocardiography | 4 | 2022 | 5103 | 0.240 |
Why?
|
| Hospitals, Pediatric | 2 | 2018 | 1766 | 0.230 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2022 | 1356 | 0.230 |
Why?
|
| Treatment Outcome | 27 | 2024 | 63119 | 0.220 |
Why?
|
| Embolism, Fat | 1 | 2003 | 47 | 0.220 |
Why?
|
| Scimitar Syndrome | 1 | 2022 | 31 | 0.210 |
Why?
|
| Purinergic P1 Receptor Agonists | 4 | 2002 | 38 | 0.210 |
Why?
|
| Heart Arrest, Induced | 3 | 2019 | 355 | 0.210 |
Why?
|
| Aortic Valve Stenosis | 1 | 2014 | 1965 | 0.210 |
Why?
|
| Cardiopulmonary Bypass | 4 | 2021 | 1066 | 0.210 |
Why?
|
| Heart Block | 1 | 2023 | 410 | 0.200 |
Why?
|
| Postoperative Complications | 11 | 2019 | 15294 | 0.200 |
Why?
|
| Pulmonary Alveoli | 2 | 2002 | 675 | 0.180 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 3508 | 0.180 |
Why?
|
| Anti-Ulcer Agents | 1 | 2020 | 119 | 0.170 |
Why?
|
| Mitral Valve | 3 | 2021 | 1490 | 0.170 |
Why?
|
| Sheep, Domestic | 1 | 2019 | 49 | 0.170 |
Why?
|
| Histamine H2 Antagonists | 1 | 2020 | 165 | 0.170 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2002 | 273 | 0.170 |
Why?
|
| Elastin | 1 | 2020 | 308 | 0.170 |
Why?
|
| Heart Injuries | 2 | 2019 | 209 | 0.160 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2022 | 349 | 0.160 |
Why?
|
| Fluorescein | 1 | 2019 | 171 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2002 | 374 | 0.160 |
Why?
|
| Tretinoin | 1 | 2001 | 517 | 0.160 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2019 | 194 | 0.160 |
Why?
|
| Male | 52 | 2023 | 350027 | 0.160 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 709 | 0.150 |
Why?
|
| Bronchoscopy | 1 | 2023 | 862 | 0.150 |
Why?
|
| Time Factors | 15 | 2019 | 40063 | 0.150 |
Why?
|
| Female | 49 | 2023 | 380197 | 0.150 |
Why?
|
| Trachea | 2 | 2023 | 1075 | 0.150 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2016 | 11 | 0.150 |
Why?
|
| Renal Replacement Therapy | 1 | 2019 | 258 | 0.150 |
Why?
|
| Sus scrofa | 2 | 2016 | 437 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 1107 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2024 | 1130 | 0.140 |
Why?
|
| Spinal Cord Ischemia | 3 | 2002 | 93 | 0.140 |
Why?
|
| Stents | 4 | 2023 | 3280 | 0.140 |
Why?
|
| Hemangioma | 1 | 2002 | 737 | 0.140 |
Why?
|
| Milrinone | 1 | 2016 | 84 | 0.140 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 879 | 0.140 |
Why?
|
| Pulmonary Veins | 1 | 2022 | 761 | 0.140 |
Why?
|
| Models, Animal | 2 | 2023 | 2171 | 0.140 |
Why?
|
| Suture Techniques | 1 | 2001 | 798 | 0.140 |
Why?
|
| Blalock-Taussig Procedure | 2 | 2016 | 62 | 0.140 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 304 | 0.140 |
Why?
|
| Transplantation, Homologous | 2 | 2018 | 4776 | 0.140 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2016 | 214 | 0.140 |
Why?
|
| Palliative Care | 6 | 2023 | 3490 | 0.140 |
Why?
|
| Vascular Resistance | 3 | 2016 | 937 | 0.140 |
Why?
|
| Infant Care | 1 | 2017 | 183 | 0.140 |
Why?
|
| Survival Rate | 10 | 2019 | 12781 | 0.130 |
Why?
|
| Heart Failure | 4 | 2014 | 10905 | 0.130 |
Why?
|
| Organ Size | 6 | 2002 | 2252 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2011 | 364 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 11728 | 0.130 |
Why?
|
| Saphenous Vein | 1 | 2018 | 532 | 0.130 |
Why?
|
| Transplantation, Autologous | 2 | 2018 | 2124 | 0.130 |
Why?
|
| Lung Diseases | 2 | 2003 | 1885 | 0.130 |
Why?
|
| Hospital Mortality | 5 | 2019 | 5316 | 0.130 |
Why?
|
| Cell Division | 5 | 2002 | 4567 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2014 | 264 | 0.120 |
Why?
|
| Aorta, Thoracic | 3 | 2015 | 1082 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2002 | 2072 | 0.120 |
Why?
|
| Animals | 27 | 2023 | 168788 | 0.120 |
Why?
|
| Ventricular Dysfunction | 2 | 2012 | 143 | 0.120 |
Why?
|
| Device Removal | 1 | 2019 | 656 | 0.120 |
Why?
|
| Patient Selection | 3 | 2016 | 4216 | 0.120 |
Why?
|
| Pilot Projects | 3 | 2024 | 8321 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 2267 | 0.110 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 592 | 0.110 |
Why?
|
| Risk Adjustment | 1 | 2017 | 594 | 0.110 |
Why?
|
| Fluorescent Dyes | 2 | 2019 | 1917 | 0.110 |
Why?
|
| Regeneration | 2 | 2002 | 1485 | 0.110 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 752 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 19907 | 0.110 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2013 | 428 | 0.110 |
Why?
|
| Stroke Volume | 2 | 2019 | 5008 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2014 | 520 | 0.110 |
Why?
|
| Age Factors | 3 | 2019 | 18367 | 0.110 |
Why?
|
| Troponin I | 1 | 2016 | 619 | 0.110 |
Why?
|
| Heart Bypass, Right | 1 | 2012 | 74 | 0.110 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2015 | 641 | 0.100 |
Why?
|
| Resuscitation | 1 | 2016 | 657 | 0.100 |
Why?
|
| Adolescent | 17 | 2019 | 85759 | 0.100 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2001 | 1186 | 0.100 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2009 | 183 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 2148 | 0.100 |
Why?
|
| Action Potentials | 1 | 2019 | 1815 | 0.100 |
Why?
|
| Spinal Cord | 5 | 2002 | 1809 | 0.100 |
Why?
|
| Ventricular Function | 2 | 2012 | 416 | 0.100 |
Why?
|
| Organ Preservation | 3 | 2002 | 331 | 0.100 |
Why?
|
| Reperfusion | 2 | 2002 | 284 | 0.100 |
Why?
|
| Heart-Assist Devices | 5 | 2010 | 1196 | 0.090 |
Why?
|
| Alagille Syndrome | 1 | 2010 | 35 | 0.090 |
Why?
|
| Paralysis | 2 | 2002 | 249 | 0.090 |
Why?
|
| Coronary Angiography | 3 | 2018 | 4578 | 0.090 |
Why?
|
| Oxygen | 3 | 2017 | 4187 | 0.090 |
Why?
|
| Postoperative Care | 1 | 2016 | 1485 | 0.090 |
Why?
|
| Prostheses and Implants | 3 | 2009 | 1387 | 0.090 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 579 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2014 | 5982 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 3 | 2022 | 1475 | 0.080 |
Why?
|
| Waiting Lists | 2 | 2010 | 693 | 0.080 |
Why?
|
| Blood Group Incompatibility | 1 | 2009 | 145 | 0.080 |
Why?
|
| Rabbits | 10 | 2003 | 4892 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2013 | 8302 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2015 | 1531 | 0.080 |
Why?
|
| Pulmonary Atresia | 1 | 2009 | 160 | 0.080 |
Why?
|
| Young Adult | 8 | 2019 | 56436 | 0.080 |
Why?
|
| Quality of Life | 2 | 2023 | 12805 | 0.080 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2009 | 150 | 0.080 |
Why?
|
| Heart Function Tests | 2 | 2012 | 330 | 0.070 |
Why?
|
| ABO Blood-Group System | 1 | 2009 | 367 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2018 | 7730 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2029 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2002 | 6078 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2020 | 6442 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2732 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 2019 | 1971 | 0.070 |
Why?
|
| Swine | 3 | 2019 | 5940 | 0.070 |
Why?
|
| Aftercare | 2 | 2023 | 866 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 5221 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2013 | 831 | 0.070 |
Why?
|
| Receptors, Purinergic P1 | 2 | 2002 | 109 | 0.070 |
Why?
|
| Child Development | 1 | 2017 | 2223 | 0.070 |
Why?
|
| Adult | 18 | 2023 | 214035 | 0.070 |
Why?
|
| Aneurysm | 1 | 2008 | 339 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2019 | 23337 | 0.060 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 39045 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2002 | 5180 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2018 | 10250 | 0.060 |
Why?
|
| Receptor, Adenosine A2A | 5 | 2002 | 124 | 0.060 |
Why?
|
| Wound Healing | 2 | 2009 | 2785 | 0.060 |
Why?
|
| Risk Factors | 10 | 2023 | 72280 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 2008 | 1416 | 0.060 |
Why?
|
| Disease Models, Animal | 7 | 2016 | 18027 | 0.060 |
Why?
|
| Thiocarbamates | 1 | 2003 | 31 | 0.060 |
Why?
|
| Antibodies | 1 | 2012 | 2461 | 0.060 |
Why?
|
| Graft Rejection | 4 | 2012 | 4399 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2018 | 987 | 0.060 |
Why?
|
| Rats | 4 | 2013 | 24273 | 0.060 |
Why?
|
| Prosthesis Failure | 1 | 2008 | 1206 | 0.060 |
Why?
|
| Prolapse | 1 | 2022 | 68 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15070 | 0.050 |
Why?
|
| Heart Diseases | 2 | 2009 | 2790 | 0.050 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2002 | 61 | 0.050 |
Why?
|
| Ulcer | 1 | 2024 | 209 | 0.050 |
Why?
|
| Cryopreservation | 2 | 2010 | 670 | 0.050 |
Why?
|
| Filtration | 1 | 2003 | 234 | 0.050 |
Why?
|
| Polyethylene Terephthalates | 1 | 2002 | 116 | 0.050 |
Why?
|
| Intensive Care Units | 3 | 2020 | 3680 | 0.050 |
Why?
|
| Ventricular Function, Left | 2 | 2011 | 3669 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 1 | 2001 | 44 | 0.050 |
Why?
|
| Cytokines | 1 | 2016 | 7326 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2009 | 1583 | 0.050 |
Why?
|
| Thrombosis | 1 | 2015 | 2968 | 0.050 |
Why?
|
| Pyrrolidines | 1 | 2003 | 342 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2012 | 3741 | 0.050 |
Why?
|
| Prospective Studies | 5 | 2020 | 53280 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2002 | 193 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 424 | 0.050 |
Why?
|
| Angiography | 2 | 2008 | 1638 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 13096 | 0.050 |
Why?
|
| Shock | 1 | 2003 | 318 | 0.050 |
Why?
|
| Epoprostenol | 1 | 2001 | 254 | 0.050 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2001 | 219 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2001 | 404 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2001 | 193 | 0.040 |
Why?
|
| Sternum | 1 | 2001 | 177 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2023 | 3313 | 0.040 |
Why?
|
| Zoonoses | 1 | 2001 | 185 | 0.040 |
Why?
|
| Suction | 1 | 2001 | 267 | 0.040 |
Why?
|
| Spectrum Analysis | 1 | 2021 | 454 | 0.040 |
Why?
|
| Recovery of Function | 3 | 2018 | 2925 | 0.040 |
Why?
|
| United States | 6 | 2023 | 69867 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2023 | 5076 | 0.040 |
Why?
|
| Critical Illness | 2 | 2024 | 2670 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2001 | 961 | 0.040 |
Why?
|
| Gadolinium | 2 | 2001 | 952 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 916 | 0.040 |
Why?
|
| Multiple Trauma | 1 | 2001 | 367 | 0.040 |
Why?
|
| Aneurysm, False | 1 | 2001 | 276 | 0.040 |
Why?
|
| Boston | 3 | 2018 | 9311 | 0.040 |
Why?
|
| Capillaries | 1 | 2002 | 774 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2001 | 414 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2001 | 407 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2008 | 2044 | 0.040 |
Why?
|
| Particle Size | 1 | 2003 | 1642 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 2002 | 977 | 0.040 |
Why?
|
| Aortic Aneurysm | 1 | 2003 | 643 | 0.040 |
Why?
|
| Perfusion | 1 | 2002 | 1359 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2001 | 6367 | 0.040 |
Why?
|
| Mucus | 1 | 2019 | 321 | 0.040 |
Why?
|
| Graft Survival | 4 | 2018 | 3740 | 0.040 |
Why?
|
| Tissue Donors | 2 | 2009 | 2242 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2002 | 855 | 0.040 |
Why?
|
| Perioperative Care | 2 | 2016 | 1000 | 0.040 |
Why?
|
| Quality of Health Care | 1 | 2012 | 4371 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2001 | 952 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 977 | 0.040 |
Why?
|
| Adenosine | 1 | 2001 | 825 | 0.030 |
Why?
|
| Morbidity | 1 | 2022 | 1769 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2005 | 2246 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 2016 | 216 | 0.030 |
Why?
|
| Middle Aged | 15 | 2019 | 213367 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 941 | 0.030 |
Why?
|
| Cardiomyopathies | 2 | 2012 | 1913 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2002 | 4217 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2001 | 792 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 1442 | 0.030 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5319 | 0.030 |
Why?
|
| Antioxidants | 1 | 2003 | 1663 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2020 | 1841 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2001 | 984 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2012 | 2619 | 0.030 |
Why?
|
| Kinetics | 1 | 2002 | 6474 | 0.030 |
Why?
|
| Consensus | 1 | 2023 | 2958 | 0.030 |
Why?
|
| Hemodynamics | 3 | 2012 | 4199 | 0.030 |
Why?
|
| Aorta | 1 | 2022 | 2061 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2018 | 1423 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 1999 | 0.030 |
Why?
|
| Carotid Stenosis | 1 | 2001 | 854 | 0.030 |
Why?
|
| Leukocytes | 1 | 2001 | 2040 | 0.030 |
Why?
|
| Papillary Muscles | 1 | 2013 | 203 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 979 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2001 | 2382 | 0.030 |
Why?
|
| Ischemia | 1 | 2001 | 1914 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2018 | 2886 | 0.030 |
Why?
|
| Fourier Analysis | 1 | 2013 | 447 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2019 | 2110 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2001 | 2131 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2001 | 2289 | 0.030 |
Why?
|
| Computer Systems | 1 | 2013 | 483 | 0.030 |
Why?
|
| Body Weight | 1 | 2002 | 4666 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2047 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2016 | 35423 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 950 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2016 | 1132 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1540 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 1009 | 0.020 |
Why?
|
| Cross Infection | 1 | 2020 | 1416 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8950 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2017 | 780 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 2019 | 2480 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4419 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2017 | 5102 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 2272 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 1869 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 1504 | 0.020 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2009 | 45 | 0.020 |
Why?
|
| Replantation | 1 | 2010 | 148 | 0.020 |
Why?
|
| Peroxidase | 2 | 2002 | 611 | 0.020 |
Why?
|
| Birth Weight | 1 | 2017 | 2069 | 0.020 |
Why?
|
| Bronchitis | 1 | 2009 | 201 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 881 | 0.020 |
Why?
|
| North America | 1 | 2012 | 1250 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2016 | 978 | 0.020 |
Why?
|
| Pneumonia | 1 | 2020 | 2134 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7799 | 0.020 |
Why?
|
| Neurologic Examination | 2 | 2001 | 931 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2019 | 3107 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12244 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6535 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 453 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2012 | 754 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7303 | 0.020 |
Why?
|
| Cause of Death | 2 | 2012 | 3584 | 0.020 |
Why?
|
| Foreign-Body Migration | 1 | 2009 | 221 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1955 | 0.020 |
Why?
|
| Respiratory Function Tests | 2 | 2001 | 1618 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2009 | 579 | 0.020 |
Why?
|
| Macrophages | 1 | 2001 | 5657 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12035 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 1585 | 0.020 |
Why?
|
| Cardiology | 1 | 2017 | 1668 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1421 | 0.020 |
Why?
|
| Apoptosis | 1 | 2001 | 9728 | 0.020 |
Why?
|
| Catheterization | 1 | 2010 | 1469 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2008 | 934 | 0.020 |
Why?
|
| Algorithms | 1 | 2005 | 13885 | 0.020 |
Why?
|
| Radiography | 1 | 2015 | 7022 | 0.010 |
Why?
|
| Aged | 8 | 2003 | 163253 | 0.010 |
Why?
|
| Reference Values | 2 | 2001 | 4982 | 0.010 |
Why?
|
| Parents | 1 | 2017 | 3407 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9960 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 40559 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 804 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2008 | 553 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3922 | 0.010 |
Why?
|
| Thromboembolism | 1 | 2009 | 985 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 719 | 0.010 |
Why?
|
| Blood Pressure | 3 | 2002 | 8551 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2002 | 255 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12355 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2017 | 3746 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2002 | 322 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 1132 | 0.010 |
Why?
|
| Micropore Filters | 1 | 2001 | 23 | 0.010 |
Why?
|
| Vacuum | 1 | 2001 | 65 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 2010 | 1440 | 0.010 |
Why?
|
| Lung Compliance | 1 | 2001 | 195 | 0.010 |
Why?
|
| Occlusive Dressings | 1 | 2001 | 50 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 404 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 534 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2001 | 205 | 0.010 |
Why?
|
| Biopsy | 1 | 2012 | 6757 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29050 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15538 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2002 | 689 | 0.010 |
Why?
|
| Pneumonia, Bacterial | 1 | 2002 | 316 | 0.010 |
Why?
|
| Thoracotomy | 1 | 2001 | 363 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2001 | 389 | 0.010 |
Why?
|
| Surgical Instruments | 1 | 2001 | 395 | 0.010 |
Why?
|
| Aerosols | 1 | 2001 | 623 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2001 | 1104 | 0.010 |
Why?
|
| Debridement | 1 | 2001 | 492 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2001 | 369 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 2001 | 529 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2001 | 1584 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2001 | 653 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3701 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2001 | 14726 | 0.010 |
Why?
|
| Probability | 1 | 2001 | 2505 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2002 | 821 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 10387 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2003 | 2501 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4929 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 3582 | 0.010 |
Why?
|
| Intracranial Aneurysm | 1 | 2001 | 1197 | 0.010 |
Why?
|
| Cell Survival | 1 | 2001 | 5881 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3800 | 0.010 |
Why?
|
| Hypertension, Pulmonary | 1 | 2001 | 1536 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5396 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 13409 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2002 | 14556 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15161 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13280 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 21824 | 0.000 |
Why?
|
| Neurons | 1 | 2001 | 9335 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2001 | 20123 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 57768 | 0.000 |
Why?
|
| Mice | 1 | 2002 | 81178 | 0.000 |
Why?
|